820 860
[14]
Mosharafa AA, Foster RS, Koch MO, Bihrle R, Donohue JP. Complica- tions of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 2004;171:1839–41.[15]
Chang SS, Smith JA, Girasole C, Baumgartner RG, Roth BJ, Cookson MS. Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissec- tion. J Urol 2002;168:87–92.
[16]
Stephenson AJ, Bosl GJ, Bajorin DF, Stasi J, Motzer RJ, Sheinfeld J. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion. J Urol 2005;174:557–60.
[17]
Daneshmand S, Albers P, Fossa˚ SD, et al. Contemporary manage- ment of postchemotherapy testis cancer. Eur Urol 2012;62:867–76.
[18]
Rob C. Extraperitoneal approach to the abdominal aorta. Surgery 1963;53:87–9.
[19]
Quick CR, Chan CL, Sonoda LI, Hart AJ. Midline extraperitoneal approach for elective abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 1997;14:63–8.
[20]
Igari T, Hoshino S, Iwaya F, et al. Results of 256 consecutive abdominal aortic aneurysm repairs using extraperitoneal approach. Cardiovasc Surg 2001;9:249–53.
[21]
Cambria RP, Brewster DC, Abbott WM, et al. Transperitoneal versus retroperitoneal approach for aortic reconstruction: a randomized prospective study. J Vasc Surg 1990;11:314–24.
[22]
Christmas TJ, Doherty AP, Rustin GJ, Seckl MJ, Newlands ES. Excision of residual masses of metastatic germ cell tumours after chemo- therapy: the role of extraperitoneal surgical approaches. Br J Urol 1998;81:301–8.
[23]
Steiner H, Leonhartsberger N, Stoehr B, Peschel R, Pichler R. Post- chemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients. Eur Urol 2013;63:1013–7.
[24]
Davol P, Sumfest J, Rukstalis D. Robotic-assisted laparoscopic retro- peritoneal lymph node dissection. Urology 2006;67:199.
[25]
Stepanian S, Patel M, Porter J. Robot-assisted laparoscopic retro- peritoneal lymph node dissection for testicular cancer: evolution of the technique. Eur Urol 2016;70:661–7.[26]
Pearce SM, Golan S, Gorin MA, et al. Safety and early oncologic effectiveness of primary robotic retroperitoneal lymph node dis- section for nonseminomatous germ cell testicular cancer. Eur Urol 2017;71:476–82.
E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 8 1 4 – 8 2 0
820